logo
Select company
Select metric
$ -23.25MConsolidated Income
VS
Market
27
Sector
53
Industry
66
History
80
$ 4.48Close
$ 3.62 - $ 6.75 52-Week Range
Ticker Information

Ticker

PLUR

Company Name

PLURI INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PLURI INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PLUR - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -23.25M
3/31/2025$ -21.34M
12/31/2024$ -20.4M
9/30/2024$ -22.28M
6/30/2024$ -21.34M
3/31/2024$ -22.09M
12/31/2023$ -24.46M
9/30/2023$ -27.72M
6/30/2023$ -28.89M
3/31/2023$ -31.36M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PLURI INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -30.5M.
  • Over the past 5 years, PLURI INC's average Cons. Inc. has been $ -33.28M.
  • The median Cons. Inc. for PLURI INC during this period was $ -30.93M
  • PLURI INC reached its highest Cons. Inc. over the past 5 years at $ -20.4M.
  • The lowest Cons. Inc. recorded by PLURI INC in the same timeframe $ -52.81M

PLURI INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
RANI : RANI THERAPEUTICS HOLDINGS INC $ -52.41MIGC : IGC PHARMA INC $ -6.34MCLSD : CLEARSIDE BIOMEDICAL INC $ -27.71MDTIL : PRECISION BIOSCIENCES INC $ -78.25MSONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ -13.56MLSTA : LISATA THERAPEUTICS INC $ -18.92MADVM : ADVERUM BIOTECHNOLOGIES INC $ -183.87MRNXT : RENOVORX INC $ -10.66MCLNN : CLENE INC $ -29.7MRLYB : RALLYBIO CORP $ -41.65M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

PLUR - Consolidated Income, Last 5 years

$ -52.81M

Minimum

Sep 30, 2021

$ -20.4M

Maximum

Dec 31, 2024

$ -33.28M

Average

$ -30.93M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.09M with a standard deviation of $ 116.52M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.09M
median$ -2.07M
std$ 116.52M